Follow us:

MedWatch Safety Alerts

MedWatch Safety Alert RSS Feed

FDA MedWatch Safety Alerts

Administration of a drug product intended to be sterile that is compromised can result in health hazards including risk of serious infection or other complications.
Posted: July 22, 2016, 6:15 pm
Risk of surgical intervention to retrieve a separated segment, or other serious adverse health consequences such as internal organ injury, stroke, kidney failure, intestinal failure, and death.
Posted: July 22, 2016, 2:00 pm
Reports of hair loss, hair breakage, balding, itching, and rash.
Posted: July 19, 2016, 5:00 pm
The agency confirmed the product has been contaminated with Burkholderia Cepacia, a bacteria linked to an outbreak in five states.
Posted: July 16, 2016, 4:00 am
Alere is working with the FDA to determine the most appropriate timing for product discontinuation and will provide guidance on transitioning patients to an alternate solution.
Posted: July 12, 2016, 7:30 pm
Sibutramine may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Posted: July 5, 2016, 4:30 pm
Batteries may lose power prematurely due to faulty cells.
Posted: June 29, 2016, 4:20 pm
Revised warnings in the drug labels to include information about acute kidney injury and added recommendations to minimize this risk.
Posted: June 14, 2016, 2:00 pm
Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Posted: June 8, 2016, 6:20 pm
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Posted: June 7, 2016, 6:55 pm
Majority of reported problems occurred in individuals intentionally misusing and abusing high doses of loperamide in attempts to self-treat opioid withdrawal symptoms or to achieve a feeling of euphoria.
Posted: June 7, 2016, 1:00 pm
Risk of serious bleeding when using nonprescription, also known as over-the-counter or OTC, aspirin-containing antacid products.
Posted: June 6, 2016, 4:00 am
Reports of severe redness, pain, skin discoloration, blistering, and cracked skin.
Posted: June 2, 2016, 5:00 pm
There may be a higher risk of patient infection associated with surgeries that introduced a prosthetic product/material [e.g., heart valve, graft, LVAD], or heart transplants when the 3T was used.
Posted: June 1, 2016, 5:55 pm
Manufacturing defect causes an increase in temperature within battery that may cause a fire.
Posted: May 27, 2016, 2:55 pm
Y-shaped connector and the yellow tube may disconnect from each other prior to or during use. This could lead to blood or fluid leakage, which may result in serious adverse health consequences, including death.
Posted: May 26, 2016, 5:10 pm
Skin and nail fungal infections in otherwise healthy persons are not life-threatening, and so the risks associated with oral ketoconazole outweigh the benefits. Posted 05/19/2016
Posted: May 19, 2016, 4:00 am
Administration of a drug product intended to be sterile that is compromised may result in serious and potentially life-threatening infections or death.
Posted: May 18, 2016, 5:00 pm
FDA is currently investigating this new safety issue. Patients should not stop or change their diabetes medicines.
Posted: May 18, 2016, 4:56 pm
Sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
Posted: May 13, 2016, 2:50 pm